Now Hiring: Strategy Intern
Tuesday, 20 December, 2016
Access to Medicine Foundation
The Access to Medicine Foundation is looking for a paid intern who will support the Deputy Director of Strategy to enhance the impact of our products, engage with investors in pharmaceutical companies and raise funds from governments and private foundations.
We are seeking a motivated intern who will will work under the supervision of the Deputy Director of Strategy. Tasks will focus on three areas: (1) strategy, (2) investor engagement, and (3) fundraising. In a small organisation like the Access to Medicine Foundation, the intern will have ample opportunity to learn and actively participate in various aspects of our work. The intern will be asked to assist in administrative tasks when necessary.
Role and responsibilities
As an intern, you will support the work of the Access to Medicine Foundation with respect to three pillars: 1) strategy; 2) fund-raising; and 3) investor engagement.
- Explore potential synergies and partnerships with other organizations
- Prepare briefings in view of meetings and calls
- Assist with outreach activities
- Track the activities of governments and private foundations in the field of global health and responsible business conduct
- Map and prioritize funding opportunities
- Draft funding applications
- Investor engagement
- Report on developments in the field of responsible investment
- Assist investors’ engagement with pharmaceutical companies
- Explore the business case for the inclusion of access to medicine issues into investors’ decisions
Profile and essential skills
- A Master- or PhD-level student in health (such as pharmacy, public health or global health) or responsible business conduct (such as responsible investment, ESG, or business and human rights)
- Availability for a minimum of 3 months to work 32, 36 or 40 hrs a week
- Familiarity with access to medicine issues, and the relevant role of pharmaceutical companies
- Track record in academic excellence
- Proactive participation in extra-curricular initiatives
- Ability to summarize complex information
- Excellent written and spoken English
- Attention to detail
How to apply
Interested candidates should send a CV, two reference letters and one writing sample to Mireille Deen, firstname.lastname@example.org.
Applications will be reviewed on a rolling basis, and interviews will take place in January 2017.
Image credit: Nathan Stephens https://www.flickr.com/photos/groundswellzoo/
About the Access to Medicine Index
The Access to Medicine Index analyses 20 of the world’s largest research-based pharmaceutical companies with products for high-burden diseases in low- and middle-income countries. The Index ranks these companies according to their efforts to improve access to medicine in seven areas of corporate behaviour, including pricing, patents, ethical behaviour and donations. It covers 107 low- and middle-income countries and 50 high-burden diseases, and examines eight types of products, from medicines to vaccines to diagnostics. The Index identifies best practices, highlights where progress is being made, and uncovers where critical action is still required. In this way, the Index provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. It is published every two years by the Access to Medicine Foundation, an independent non-profit organisation.
About the Access to Medicine Foundation
The Access to Medicine Foundation is an independent, nonprofit organisation based in the Netherlands. It aims to advance access to medicine in low- and middle-income countries by stimulating and guiding the pharmaceutical industry to play a greater role in improving access to medicine. The Foundation is funded by the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs and the UK Department for International Development. For ten years, the Foundation has been building consensus on the role for the pharmaceutical industry in improving access to medicine and vaccines. It published its first benchmark of industry activity in this area in 2008, in the first Access to Medicine Index. The fifth Access to Medicine Index was published in November 2016. In 2017, the Foundation will publish the first Access to Vaccines Index, funded by the Dutch National Postcode Lottery, and the first AntiMicrobial Benchmark, funded by the UK and Dutch governments.